Newsroom
-
Mammoth Biosciences Grabs $23 Million for Crispr-Based Disease Detection
The Wall Street JournalLearn More -
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
ScienceLearn More -
Mammoth Biosciences Launches to Develop World’s First CRISPR-Based Detection Platform
WebWireLearn More -